| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 300.262 | 30.482 | 0 | 0 | 20.875 | 378.069 | 751.690 | 115.222 |
| Total Income - EUR | - | - | 300.262 | 30.606 | -12 | -32 | 20.875 | 379.081 | 751.690 | 383.034 |
| Total Expenses - EUR | - | - | 148.352 | 46.360 | 20.873 | 29.173 | 18.265 | 350.623 | 572.954 | 122.915 |
| Gross Profit/Loss - EUR | - | - | 151.910 | -15.754 | -20.885 | -29.206 | 2.609 | 28.458 | 178.736 | 260.119 |
| Net Profit/Loss - EUR | - | - | 149.129 | -16.062 | -20.885 | -29.205 | 2.609 | 24.538 | 172.121 | 252.405 |
| Employees | - | - | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Nanotech Health Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 15.990 | 11.021 | 6.245 | 1.776 | 403.690 | -43.998 | 492.434 |
| Current Assets | - | - | 121.481 | 115.022 | 18.114 | 23.466 | 397.254 | 480.820 | 762.237 | 386.364 |
| Inventories | - | - | 2.018 | 18.394 | 10.991 | 11.167 | 430 | 0 | 14.954 | 14.870 |
| Receivables | - | - | 113.675 | 105.748 | 14.660 | 12.325 | 382.701 | 425.298 | 653.602 | 287.353 |
| Cash | - | - | 5.788 | -9.120 | -7.538 | -26 | 14.123 | 55.523 | 93.682 | 84.141 |
| Shareholders Funds | - | - | 149.173 | 118.113 | 20.774 | 11.664 | 14.015 | 39.495 | 211.497 | 462.720 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 7.334 | 12.914 | 8.363 | 18.048 | 385.017 | 845.018 | 506.744 | 657.228 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4100 - 4100" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Nanotech Health Srl